Szymanowski J, Baranowska B, Rozbicka G, Jeske W, Zgliczynski S
J Urol (Paris). 1983;89(9):663-8.
The aim of this study was to estimate the relations between oestrogen, progesterone, prolactin (PRL) and gonadotrophin levels and the degree of advancement as well as that of malignancy of carcinoma of the prostate. Serum LH and FSH levels were determined under baseline conditions and after stimulation with LH-RH. In patients with metastases and in less differentiated forms of carcinoma the level of oestradiol (E2) was significantly higher. The testosterone/oestradiol ratio was notably lower in patients without metastases and in more differentiated forms. Serum progesterone was significantly higher in less differentiated forms of carcinoma. The concentration of LH in response to the administration of LH-RH was significantly higher in patients with metastases. Measurement of hormone levels at certain stages in the course of carcinoma of the prostate may be of practical value in the choice of appropriate hormone treatment.
本研究的目的是评估雌激素、孕酮、催乳素(PRL)和促性腺激素水平与前列腺癌进展程度以及恶性程度之间的关系。在基线条件下以及用促黄体生成素释放激素(LH-RH)刺激后测定血清促黄体生成素(LH)和促卵泡生成素(FSH)水平。在有转移的患者以及分化程度较低的癌组织中,雌二醇(E2)水平显著更高。在无转移且分化程度较高的患者中,睾酮/雌二醇比值显著更低。在分化程度较低的癌组织中,血清孕酮显著更高。在有转移的患者中,给予LH-RH后LH的浓度显著更高。在前列腺癌病程的特定阶段测量激素水平可能对选择合适的激素治疗具有实际价值。